IP Library Granted Patent US 11,332,763
Granted Patent B2
US 11,332,763 · App. 15/568,347 · Granted May 17, 2022

Mutant microorganisms and methods of making and using

Inventors: Raghuveer Singh (Lincoln, NE); Derrick White (Lincoln, NE); Paul Blum (Lincoln, NE)
Assignee: NUtech Ventures
C12P7/065C12N1/185C12N1/205C12N1/36C12N9/0006C12N9/1217C12N9/88C12P3/00C12P7/44C12P7/54C12Y101/01027C12Y207/02001C12Y401/0103C12Y401/01039C12R2001/145C12R2001/15C12R2001/865Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,332,763
App. No.
15/568,347
Granted
May 17, 2022
Kind
B2
Abstract

This disclosure describes methods that allow for the uncoupling of microbial growth from product formation, which allows for maximal use of raw material and optimal end-product formation.

Claims (10)

1. A Thermotoga maritima strain comprising at least one mutation in the ATP-binding component of a maltose ABC transporter, wherein the ATP-binding component of the maltose ABC transporter comprises the amino acid sequence of SEQ ID NO:15 and at least one mutation selected from V233S or V233F, wherein the T. maritima strain overproduces molecular hydrogen (H 2 ) compared to a T. maritima strain lacking the at least one mutation.

2. The strain of claim 1 , wherein the strain overproduces acetate compared to a T. maritima strain lacking the at least one mutation.

3. The strain of claim 1 , wherein the strain produces little to no lactate.

4. The strain of claim 1 , wherein the strain further comprises SEQ ID NO:16 having a W229Stop mutation and a deletion of nucleic acid sequences encoding the amino acid sequence of SEQ ID NO:17 and the amino acid sequence of SEQ ID NO:18.

5. A method of increasing the yield of molecular hydrogen (H 2 ) produced by Thermotoga maritima in culture, comprising:

inactivating, transiently, the lactate dehydrogenase gene in the T. maritima using a selectable marker to produce an inactivated T. maritima;

passaging the inactivated T. maritima a plurality of times under selective pressure to produce a compensating T. maritima , wherein the compensating T. maritima comprises a compensating mutation;

screening the compensating T. maritima for an increase in H 2 ; and

selecting and isolating the compensating T. maritima having an increase in H 2 , wherein the compensating mutation is in the ATP-binding component of a maltose ABC transporter, wherein the ATP-binding component of the maltose ABC transporter comprises the amino acid sequence of SEQ ID NO:15 and at least one mutation selected from V233S or V233F.

6. The method of claim 5 , further comprising sequencing the compensating T. maritima.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 18, 2022
From: UNIVERSITY OF NEBRASKA LINCOLN
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 059439/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2020
From: SINGH, RAGHUVEER; WHITE, DERRICK; BLUM, PAUL
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 053193/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
To: NUTECH VENTURES
Reel/Frame 045495/0149 →
Continuity (2)
Provisional Application 62150345 · Apr 21, 2015
Related Publication 20180100168A1 · Apr 12, 2018